Regulations.gov document
Guidance for Industry on Chronic Hepatitis C Virus Infection; Developing Direct-Acting…
Other · FDA-2010-D-0462 · posted Sep 14, 2010
Key facts
| Document ID | FDA-2010-D-0462-0002 |
|---|---|
| Title | Guidance for Industry on Chronic Hepatitis C Virus Infection; Developing Direct-Acting Antiviral Agents for Treatment - Draft Guidance |
| Document type | Other |
| Subtype | GDL-Guidance (Supporting and Related Materials) |
| Agency | FDA |
| Docket | FDA-2010-D-0462 |
| Posted | Sep 14, 2010 |
| Comment period opens | Sep 14, 2010 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: